» Authors » Taka-aki Koshimizu

Taka-aki Koshimizu

Explore the profile of Taka-aki Koshimizu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 1398
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Noda M, Koshu R, Shimada D, Sajjaviriya C, Saito C, Ito M, et al.
Heliyon . 2024 Oct; 10(19):e38938. PMID: 39435078
In acute aminoglycoside ototoxicity of the unilateral inner ear, physical abnormalities, such as nystagmus and postural alteration, are relieved within a few days by neural compensation. To examine exploratory behavior...
2.
Azuma M, Konno N, Sakata I, Koshimizu T, Kaiya H
Cell Tissue Res . 2024 May; 397(1):61-76. PMID: 38727755
Motilin (MLN) is a peptide hormone originally isolated from the mucosa of the porcine intestine. Its orthologs have been identified in various vertebrates. Although MLN regulates gastrointestinal motility in tetrapods...
3.
Sajjaviriya C, Fujianti , Azuma M, Tsuchiya H, Koshimizu T
Peptides . 2024 Apr; 177:171226. PMID: 38649033
Close contact between lactating rodent mothers and their infants is essential for effective nursing. Whether the mother's effort to retrieve the infants to their nest requires the vasopressin-signaling via V1b...
4.
Pidugu V, Kostic T, Andric S, Tharappel A, Koshimizu T
Front Endocrinol (Lausanne) . 2023 Jul; 14:1235274. PMID: 37435484
No abstract available.
5.
Tsuchiya H, Fujinoki M, Azuma M, Koshimizu T
Life Sci Alliance . 2023 Jan; 6(4). PMID: 36650057
Specific receptors for the neurohypophyseal hormones, arginine vasopressin (AVP) and oxytocin, are present in the male reproductive organs. However, their exact roles remain unknown. To elucidate the physiological functions of...
6.
Masuda H, Ae R, Koshimizu T, Kosami K, Makino N, Matsubara Y, et al.
Clin Rheumatol . 2022 Jul; 41(10):3125-3133. PMID: 35798922
Introduction/objectives: Serum alanine aminotransferase (ALT) elevation is considered a risk factor for resistance to initial intravenous immunoglobulin (IVIG) treatment in patients with Kawasaki disease (KD). However, serum ALT levels change...
7.
Masuda H, Ae R, Koshimizu T, Matsumura M, Kosami K, Hayashida K, et al.
Clin Rheumatol . 2021 Aug; 41(1):137-145. PMID: 34363547
Introduction/objectives: Hyponatremia is a potential risk factor for the development of coronary artery lesions (CALs) identified after acute Kawasaki disease (KD). However, the serum sodium distribution corresponding to the reference...
8.
Ngamlertwong N, Tsuchiya H, Mochimaru Y, Azuma M, Kuchimaru T, Koshimizu T
Sci Rep . 2021 Aug; 11(1):15813. PMID: 34349143
During the development of analgesic tolerance to morphine, the V1b vasopressin receptor has been proposed to bind to β-arrestin 2 and the µ-opioid receptor to enable their interaction. However, direct...
9.
Masuda H, Ae R, Koshimizu T, Matsumura M, Kosami K, Hayashida K, et al.
Pediatr Cardiol . 2021 Mar; 42(4):969-977. PMID: 33682062
A giant coronary artery (CA) aneurysm is a potentially fatal cardiac complication resulting from Kawasaki disease (KD). We aimed to identify epidemiologic characteristics and potential risk factors associated with giant...
10.
Kumazaki M, Ando H, Sasaki A, Koshimizu T, Ushijima K, Hosohata K, et al.
J Pharmacol Sci . 2020 Apr; 115(2):244-248. PMID: 32272544
The clinical use of arsenic trioxide (ATO) is often limited because of its adverse effects. We examined whether α-lipoic acid (LA) protects against the ATO-induced cardiac toxicity. In the chronic...